US Patent 9023994 Immunoglobulin reduced in thrombogenic agents and preparation thereof
Patent 9023994 was granted and assigned to Omrix Biopharmaceuticals on May, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 14, 2012
0
Date of Patent
May 5, 2015
0
Patent Application Number
13470788
0
Patent Inventor Names
Roni Mintz
0
Liliana Bar
0
Oleg Belyaev
0
Roberto Meidler
0
Israel Nur
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9023994 Immunoglobulin reduced in thrombogenic agents and preparation thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.